Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is a 16-week clinical trial in lipid clinic patients for whom niacin therapy is
appropriate to evaluate the tolerability of MK0524A versus niacin extended-release. There
will be 6 scheduled clinic visits and 2 treatment groups.